Ocugen (OCGN) Operating Income (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.97% |
| Dec 31, 2025 | 3.57% |
| Sep 30, 2025 | -27.76% |
| Jun 30, 2025 | 4.87% |
| Mar 31, 2025 | -4.78% |
| Dec 31, 2024 | -4.44% |
| Sep 30, 2024 | 14.22% |
| Jun 30, 2024 | -26.47% |
| Mar 31, 2024 | -6.00% |
| Dec 31, 2023 | 7.29% |
| Sep 30, 2023 | 47.19% |
| Jun 30, 2023 | -30.52% |
| Mar 31, 2023 | 22.78% |
| Dec 31, 2022 | 6.99% |
| Sep 30, 2022 | -16.38% |
| Jun 30, 2022 | -13.38% |
| Mar 31, 2022 | -30.59% |
| Dec 31, 2021 | -35.06% |
| Sep 30, 2021 | 57.87% |
| Jun 30, 2021 | -262.90% |
| Mar 31, 2021 | -85.32% |
| Dec 31, 2020 | 62.60% |
| Sep 30, 2020 | -202.50% |
| Jun 30, 2020 | 14.33% |
| Mar 31, 2020 | 8.19% |
| Dec 31, 2019 | -57.70% |
| Sep 30, 2019 | -16.55% |
| Jun 30, 2019 | 51.90% |
| Mar 31, 2019 | 14.91% |
| Dec 31, 2018 | -136.62% |
| Sep 30, 2018 | 66.99% |
| Jun 30, 2018 | -19.55% |
| Mar 31, 2018 | -0.99% |
| Dec 31, 2017 | -5.60% |
| Sep 30, 2017 | 10.37% |
| Jun 30, 2017 | 6.68% |
| Mar 31, 2017 | 13.61% |
| Dec 31, 2016 | -18.92% |
| Sep 30, 2016 | 16.43% |
| Jun 30, 2016 | -2.01% |
| Mar 31, 2016 | 6.21% |
| Dec 31, 2015 | -3.42% |
| Sep 30, 2015 | -5.87% |
| Jun 30, 2015 | 3.56% |
| Mar 31, 2015 | -20.40% |
| Dec 31, 2014 | 56.23% |
| Sep 30, 2014 | -148.59% |
| Jun 30, 2014 | -16.18% |